GBA1 gene therapy (Codexis)

N/A

Report date: 2025/01/26 17:50:16

Base Information

Drug NameGBA1 gene therapy (Codexis)
Drug Alias NameAAV-GBA1 gene therapy (Codexis)adeno-associated viral vector delivered human beta glucocerebrosidase gene therapy (Codexis)
ClassificationBiologics
Mechanisms of ActionBeta-glucocerebrosidase stimulants
TargetsBeta-glucocerebrosidase
Therapy Area/IndicationsGaucher Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCodexis Inc
China Registration ClassN/A

Develop Information

Active CompaniesCodexis Inc
Inactive CompaniesN/A
Active IndicationsGaucher Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A